C.K. Atterwill

1.2k total citations
75 papers, 964 citations indexed

About

C.K. Atterwill is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, C.K. Atterwill has authored 75 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cellular and Molecular Neuroscience, 25 papers in Molecular Biology and 12 papers in Pharmacology. Recurrent topics in C.K. Atterwill's work include Neuroscience and Neuropharmacology Research (22 papers), Thyroid Disorders and Treatments (10 papers) and Cholinesterase and Neurodegenerative Diseases (9 papers). C.K. Atterwill is often cited by papers focused on Neuroscience and Neuropharmacology Research (22 papers), Thyroid Disorders and Treatments (10 papers) and Cholinesterase and Neurodegenerative Diseases (9 papers). C.K. Atterwill collaborates with scholars based in United Kingdom, Canada and United States. C.K. Atterwill's co-authors include Wendy M. Purcell, A. K. Prince, R. Balázs, Vincent J. Cunningham, David J. Heal, S.M. Thomas, Sharon L. Smith, David Atkinson, M. Bloomfield and Ann E. Kingsbury and has published in prestigious journals such as Neuroscience, Journal of Neurochemistry and British Journal of Pharmacology.

In The Last Decade

C.K. Atterwill

70 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.K. Atterwill United Kingdom 17 326 321 147 120 110 75 964
Kyoji Morita Japan 20 419 1.3× 243 0.8× 76 0.5× 97 0.8× 162 1.5× 76 1.2k
D. Esposti Italy 19 286 0.9× 149 0.5× 65 0.4× 82 0.7× 179 1.6× 30 1.3k
P.-M. Sinet France 18 532 1.6× 173 0.5× 37 0.3× 92 0.8× 249 2.3× 27 1.4k
Hugh E. Laird United States 22 592 1.8× 805 2.5× 59 0.4× 69 0.6× 193 1.8× 45 1.5k
Jörg Lindenau Germany 6 614 1.9× 403 1.3× 31 0.2× 93 0.8× 275 2.5× 8 1.7k
Mario Rossi Italy 22 723 2.2× 389 1.2× 156 1.1× 118 1.0× 133 1.2× 57 1.3k
András Seregi Hungary 18 451 1.4× 295 0.9× 45 0.3× 241 2.0× 205 1.9× 33 991
Felicitas S. Cabbat United States 20 634 1.9× 875 2.7× 65 0.4× 160 1.3× 285 2.6× 25 2.1k
Jan Seyfried Germany 13 814 2.5× 343 1.1× 32 0.2× 100 0.8× 276 2.5× 14 1.7k
C.G. Honegger Switzerland 19 399 1.2× 249 0.8× 46 0.3× 61 0.5× 132 1.2× 60 1.3k

Countries citing papers authored by C.K. Atterwill

Since Specialization
Citations

This map shows the geographic impact of C.K. Atterwill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.K. Atterwill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.K. Atterwill more than expected).

Fields of papers citing papers by C.K. Atterwill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.K. Atterwill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.K. Atterwill. The network helps show where C.K. Atterwill may publish in the future.

Co-authorship network of co-authors of C.K. Atterwill

This figure shows the co-authorship network connecting the top 25 collaborators of C.K. Atterwill. A scholar is included among the top collaborators of C.K. Atterwill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.K. Atterwill. C.K. Atterwill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heal, David J., Jane Gosden, Sharon L. Smith, & C.K. Atterwill. (2022). Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines. Neuropharmacology. 225. 109375–109375. 13 indexed citations
2.
Walker, Tracy, et al.. (1999). The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its metabolites on rat brain spheroids in culture. Cell Biology and Toxicology. 15(3). 137–142. 6 indexed citations
3.
Atterwill, C.K., et al.. (1998). NMDA-induced increases in rat brain glutamine synthetase but not glial fibrillary acidic protein are mediated by free radicals. Neuroscience Letters. 247(1). 37–40. 8 indexed citations
4.
Atterwill, C.K., et al.. (1996). Reversal of aluminium-induced metabolic changes in primary rat midbrain neural cultures by the NMDA antagonist MK-801. Toxicology in Vitro. 10(5). 631–635. 4 indexed citations
5.
Purcell, Wendy M., Karen Doyle, Connar Stanley James Westgate, & C.K. Atterwill. (1996). Characterisation of a functional polyamine site on rat mast cells: association with a NMDA receptor macrocomplex. Journal of Neuroimmunology. 65(1). 49–53. 29 indexed citations
6.
Atterwill, C.K., et al.. (1995). In Vitro Toxicity Testing Protocols. Humana Press eBooks. 121 indexed citations
7.
Atterwill, C.K., et al.. (1995). WORKSHOP ON IN VITRO NEUROTOXICITY TESTING: THE OBSTACLES, THE WAY FORWARD. Clinical and Experimental Pharmacology and Physiology. 22(4). 277–280. 1 indexed citations
8.
Purcell, Wendy M. & C.K. Atterwill. (1994). Rodent and human mast cells as an in vitro model in neuroimmunotoxicity testing. Toxicology in Vitro. 8(4). 627–630. 1 indexed citations
9.
Jones, H. B., et al.. (1993). Effects of the neurotoxin ethylcholine mustard aziridinium in rat brain reaggregate cultures. Toxicology in Vitro. 7(1). 69–80. 1 indexed citations
10.
11.
Atterwill, C.K., et al.. (1990). Delayed treatment with Nerve Growth Factor (NGF) reverses ECMA-induced cholinergic lesions in rat brain reaggregate cultures. Biochemical Pharmacology. 39(12). 2073–2076. 3 indexed citations
12.
Atterwill, C.K. & Ian Kimber. (1990). Hyperplastic and hypertrophic responses in toxicity and carcinogenesis. Toxicology in Vitro. 4(6). 795–797. 1 indexed citations
13.
14.
Atterwill, C.K., et al.. (1989). Relation between dopaminergic control of pituitary lactotroph function and deceleration of age-related changes in serum prolactin of diet-restricted rats. Food and Chemical Toxicology. 27(2). 97–103. 6 indexed citations
15.
Atterwill, C.K., et al.. (1989). The effects of desipramine (DMI) and electroconvulsive shock (ECS) on the function of the hypothalamo-pituitary-thyroid axis in the rat. Psychoneuroendocrinology. 14(5). 339–346. 8 indexed citations
16.
17.
18.
19.
Atterwill, C.K.. (1977). PROCEEDINGS OF THE British Pharmacological Society. British Journal of Pharmacology. 61(1). 111P–112P. 6 indexed citations
20.
Atterwill, C.K., Angela Mahoney, & M J Neal. (1975). Proceedings: The uptake and subcellular distribution of 3-H-choline by the retina.. British Journal of Pharmacology. 53(3). 447. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyoji Morita Breakdown of academic impact, for papers by D. Esposti Breakdown of academic impact, for papers by P.-M. Sinet Breakdown of academic impact, for papers by Hugh E. Laird Breakdown of academic impact, for papers by Jörg Lindenau Breakdown of academic impact, for papers by Mario Rossi Breakdown of academic impact, for papers by András Seregi Breakdown of academic impact, for papers by Felicitas S. Cabbat Breakdown of academic impact, for papers by Jan Seyfried Breakdown of academic impact, for papers by C.G. Honegger
Rankless by CCL
2026